BHEL profit at Rs3,660 crore in 9 months

BHEL has maintained its track record of earning profits uninterruptedly for nearly four decades.

Bharat Heavy Electrical reported a 14% jump in net profit at Rs3,660.2 crore in the nine months ended December 2011. The power equipment major had a net profit of Rs3,213.2 crore in the year-ago period.
     
BHEL's sales climbed to Rs29,269.1 crore in the nine months under review from Rs 24,756.5 crore in the same period a year ago, the company said in a statement.
     
In the December quarter of financial year 2011-12, the company's net profit rose to Rs1,432.6 crore. The same stood at Rs1,412 crore in the year-ago period.
     
Sales in the December quarter stood at Rs11,078.3 crore as against Rs10,757.6 crore in the comparable period last year.
     
According to the statement, the company has maintained its track record of earning profits uninterruptedly for nearly four decades without a break.

In the late afternoon, Bharat Heavy Electricals Ltd was trading at around Rs248.50 per share on the Bombay Stock Exchange, 9.19% down from the previous close.

User

Pfizer Q3 net profit rises to Rs48 crore

Net sales of Pfizer India stood at Rs251.88 crore for the third quarter ended 31 December 2011.

Pfizer Ltd has reported a net profit of Rs48.28 crore for the third quarter ended 31 December 2011. The company had posted a net profit of Rs43.58 crore for the third quarter in the previous year.

As the company has changed its accounting year with effect from 1 December 2009, the third quarter results of the company are not comparable with those of the third quarter of the previous fiscal, Pfizer India said in a filing to the BSE.

Net sales of the company stood at Rs251.88 crore for the third quarter ended 31 December 2011. It stood at Rs 235.84 for the third quarter in the previous year.

For the nine months ended 31 December 2011, the company posted a net profit of Rs136.51 crore. The profit was Rs120.75 crore for the same period in the previous year.

The company was awarded the FICCI SEDF (Socio Economic Development Foundation) Certificate of Commendation for its social responsibility efforts. Pfizer has won several awards including that for the multinational pharmaceutical company of the year.
 
In the late afternoon, Pfizer Ltd was trading at around Rs1,199.90 per share on the Bombay Stock Exchange, 2.64% down from the previous close.

User

Divis Labs Q3 net up 21%

Drug firm Divis Laboratories said its net profit rose by 21% to Rs122.55 crore for the third quarter of the financial year 2011-12

Drug firm Divis Laboratories said its net profit rose by 21% to Rs122.55 crore for the third quarter ended 31 December 2011. The company had posted a net profit of Rs101.57 crore for the quarter ended 31 December 2010.
 
Total income of the company stood at Rs417.42 crore for the quarter ended 31 December 2011 as against Rs314.97 crore for the corresponding period previous fiscal, Divis Laboratories said in a filing to the BSE.

Divis Laboratories has focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company has expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

In the late afternoon, Divi's Laboratories Ltd was trading at around Rs748.40 per share on the Bombay Stock Exchange, 4.07% down from the previous close.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)